BECN1 and prostate carcinoma: Furthermore, blocking autophagy by pharmacological inhibitors or siRNAs targeting key autophagy factors Beclin1 or ATG7, effectively increases TRAIL-induced apoptotic cytotoxicity in prostate cancer cell lines [52].